(FY)Apr 30, 2024 | (Q4)Apr 30, 2024 | (Q3)Jan 31, 2024 | (Q2)Oct 31, 2023 | (Q1)Jul 31, 2023 | (FY)Apr 30, 2023 | (Q4)Apr 30, 2023 | (Q3)Jan 31, 2023 | (Q2)Oct 31, 2022 | (Q1)Jul 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | -65.02%-1.43M | -112.50%-284.57K | 14.94%-199.8K | -1,397.96%-983.67K | 109.41%40.52K | 83.34%-865.05K | 72.03%-133.91K | 62.73%-234.88K | 97.62%-65.67K | 67.57%-430.59K |
Net income from continuing operations | 63.38%-1.14M | 84.75%-208.01K | 68.08%-110.02K | -96.41%-598K | 79.68%-223.27K | 20.96%-3.11M | -27.36%-1.36M | 37.60%-344.69K | 72.22%-304.46K | 9.79%-1.1M |
Operating gains losses | -95.70%275 | ---- | ---- | ---- | ---- | 103.50%6.4K | --0 | --0 | ---- | ---- |
Depreciation and amortization | -29.30%48.22K | -80.45%3.22K | -30.33%11.64K | -5.40%16.78K | -4.15%16.58K | -33.35%68.21K | -7.19%16.46K | -11.28%16.71K | -49.99%17.74K | -42.91%17.3K |
Asset impairment expenditure | --0 | -104.09%-43.82K | --0 | ---- | ---- | --1.07M | --1.07M | --0 | ---- | ---- |
Unrealized gains and losses of investment securities | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | 62.39%9.16K |
Remuneration paid in stock | -97.29%5.07K | --0 | -107.09%-2.25K | -93.74%3.66K | -95.49%3.66K | -52.09%186.82K | -84.85%15.37K | -73.41%31.76K | -31.83%58.45K | -2.52%81.23K |
Other non cashItems | ---- | ---- | ---- | ---- | --65.18K | --8.46K | --5.7K | ---94.73K | ---- | ---- |
Change In working capital | -137.82%-341.77K | -130.04%-35.93K | -163.72%-99.46K | -666.96%-384.76K | -68.16%178.37K | 157.17%903.77K | -74.31%119.62K | 515.95%156.08K | 103.81%67.86K | 344.27%560.21K |
-Change in receivables | -119.86%-1.29K | -247.02%-5.12K | 1,189.86%11.28K | -153.90%-10.01K | 126.78%2.57K | 33.32%6.47K | 83.43%-1.48K | -108.28%-1.04K | 54.72%18.58K | 10.71%-9.6K |
-Change in prepaid assets | -98.95%7.2K | -94.74%32.52K | -90.48%4.78K | 85.77%-12.57K | -116.59%-17.53K | 145.53%685.33K | 543.94%617.78K | 921.22%50.2K | 95.06%-88.3K | -45.16%105.66K |
-Change in payables and accrued expense | -264.03%-347.69K | 87.25%-63.33K | -208.05%-115.52K | -363.24%-362.17K | -58.35%193.33K | 363.33%211.97K | -231.22%-496.68K | 343.48%106.92K | 3,681.08%137.59K | 212.86%464.15K |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | -65.02%-1.43M | -112.50%-284.57K | 14.94%-199.8K | -1,397.96%-983.67K | 109.41%40.52K | 83.34%-865.05K | 72.03%-133.91K | 62.73%-234.88K | 97.62%-65.67K | 67.57%-430.59K |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | 156.84%47.77K | 47.77K | 0 | -85.60%18.6K | 0 | 0 | ||||
Net PPE purchase and sale | --47.77K | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
Net investment purchase and sale | --0 | --0 | --0 | ---- | ---- | --18.6K | --0 | --0 | ---- | ---- |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | 156.84%47.77K | --47.77K | --0 | ---- | ---- | -85.60%18.6K | --0 | --0 | ---- | ---- |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | 459.22%1.68M | 376.34%476.34K | -30.83%103.75K | 1.1M | -97.09%1.46K | -93.33%300K | 100K | 150K | 0 | -98.89%50K |
Net issuance payments of debt | -203.39%-258.46K | -200.00%-100K | -33.33%100K | ---274.96K | --16.5K | --250K | --100K | --150K | --0 | --0 |
Net common stock issuance | --2.04M | --605K | --0 | ---- | ---- | --0 | --0 | --0 | ---- | ---- |
Proceeds from stock option exercised by employees | --0 | --0 | --0 | --0 | --0 | --50K | --0 | --0 | --0 | --50K |
Net other financing activities | ---98.88K | ---28.66K | --3.75K | ---58.93K | ---15.04K | ---- | ---- | ---- | ---- | ---- |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | 459.22%1.68M | 376.34%476.34K | -30.83%103.75K | --1.1M | -97.09%1.46K | -93.33%300K | --100K | --150K | --0 | -98.89%50K |
Net cash flow | ||||||||||
Beginning cash position | -97.90%10.52K | 189.39%69.68K | 24.14%161.15K | -51.77%58.37K | -97.90%10.52K | -51.17%501.37K | -97.53%24.08K | -90.54%129.81K | -97.10%121.04K | -51.17%501.37K |
Current changes in cash | 154.52%297.92K | 806.38%239.55K | -13.16%-96.05K | 338.89%112.44K | 111.03%41.98K | 3.09%-546.45K | 92.95%-33.91K | 81.27%-84.88K | 98.31%-47.07K | -112.07%-380.59K |
Effect of exchange rate changes | -101.27%-705 | -107.32%-1.49K | 121.96%4.58K | -117.31%-9.67K | 2,158.85%5.87K | 44.61%55.6K | 166.85%20.36K | -137.59%-20.85K | 332.08%55.84K | 143.62%260 |
End cash Position | 2,824.41%307.74K | 2,824.41%307.74K | 189.39%69.68K | 24.14%161.15K | -51.77%58.37K | -97.90%10.52K | -97.90%10.52K | -97.53%24.08K | -90.54%129.81K | -97.10%121.04K |
Free cash from | -65.02%-1.43M | -112.50%-284.57K | 14.94%-199.8K | -1,397.96%-983.67K | 109.41%40.52K | 83.54%-865.05K | 72.18%-133.91K | 63.48%-234.88K | 97.64%-65.67K | 68.01%-430.59K |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.